$RGC

$6.76 -$0.91 (11.86%) Close

$RGC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 495.9M shares outstanding

Who owns RGC?

By type of holder

Institutions 0.3% Insiders 0.0% Everyone else 99.7%

Concentration Top 10 holders own 86.3%

Regencell (BVI) Limited 86.0% · Geode Capital Management, LLC 0.1%

Institutional ownership

0.3%

+0.2 pts vs last qtr

Institutional holders

+3 vs last qtr

Net shares bought

+734.5K

by institutions in Q2 2026

New / sold out

15 / 12

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Alyeska Investment Group, L.P. NEW +416.3K
Legal & General Group Plc +118.1K

Biggest sellers in Q2 2026

Marex Group Ltd SOLD OUT −31.6K
Gsa Capital Partners LLP SOLD OUT −31.6K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Regencell Bioscience Holdings Ltd in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2020–FY2026

+30.2%

+4.49% a year

Each share's claim on the business

−23.2%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $7.6M

over 7 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years37% Under 1 year63%

Quarterly turnover

76.3%

of institutional shares changed hands

Top 10 managers, median time held

1 quarter

Super Investors

Investment managers reporting RGC on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
GC Geode Capital Management, LLC	422.0K	0.09%	+6.4K (+1.6%)	2025	0.0%
Shares held by quarter Peak holding422.0K (Q2'26) Change over 8 quarters+422.0K Share of the company0.090% Geode Capital Management, LLC's full portfolio →
AI Alyeska Investment Group, L.P.	416.3K	0.08%	NEW	Q2 '26	0.0%
Shares held by quarter Peak holding416.3K (Q2'26) Change over 8 quarters+416.3K Share of the company0.080% Alyeska Investment Group, L.P.'s full portfolio →

Geode Capital Management, LLC

422.0K

% of company

0.09%

Change vs last qtr

+6.4K (+1.6%)

Held since

2025

Alyeska Investment Group, L.P.

416.3K

% of company

0.08%

Change vs last qtr

NEW

Held since

Q2 '26

28 more super investors behind a free account

See every manager holding Regencell Bioscience Holdings Ltd, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting RGC on Form N-PORT; together they hold 0.0% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IS Invesco S&P Emerging Markets Momentum ETF Invesco Exchange-Traded Fund Trust II	$2.95K	478	0.00%	0.01%	July 31, 2026

Invesco S&P Emerging Markets Momentum ETF

Invesco Exchange-Traded Fund Trust II

Position value

$2.95K

% of company

0.00%

% of the fund

0.01%

As of

July 31, 2026

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
R( Regencell (BVI) Limited 5%+ holder 13D · 86.2%	426.4M	85.99%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company85.990% Disclosed stake13D · 86.2% View the 13D/G filing →

Regencell (BVI) Limited

5%+ holder13D · 86.2%

426.4M

% of company

85.99%

Change vs last qtr

—

Held since

—

Comments